Differentiated Thyroid Cancer

Healthcare specialists provide their insight in the context of a patient’s journey with thyroid cancer, highlighting treatment options that make up today’s therapeutic landscape.

EP. 1: An Overview of Differentiated Thyroid Cancer

March 31st 2022

Health care specialists provide an overview on the nature of differentiated thyroid cancer and discuss subtypes of disease that patients may present with.

EP. 2: General Principles of Management of DTC and Role of the Health Care Team

March 31st 2022

Expert perspectives on the broad management of differentiated thyroid cancer, including surgery, radiation treatment, and systemic therapy.

EP. 3: Differentiated Thyroid Cancer: The Role of Patient Advocacy Organizations

April 7th 2022

Considerations for the role of patient advocacy groups and patient-to-patient education in the differentiated thyroid cancer journey.

EP. 4: A Patient’s Journey With Differentiated Thyroid Cancer

April 7th 2022

Jim Lesniak shares his experience of receiving a diagnosis of and being treated for differentiated thyroid cancer.

EP. 5: Radioiodine Therapy for Differentiated Thyroid Cancer Following Surgery

April 14th 2022

Expert perspectives on the process of surgery and radiation therapy used for less severe cases of differentiated thyroid cancer.

EP. 6: Identifying and Monitoring Radioiodine-Refractory DTC

April 14th 2022

Discussion on when differentiated thyroid cancer is determined to be iodine-refractory, and how patients should be followed in this setting.

EP. 7: Radioiodine-Refractory DTC: An Overview of Work-up and Treatment Options

April 21st 2022

Health care specialists share insight on the work-up of patients with iodine-refractory differentiated thyroid cancer and how this may affect systemic therapy options.

EP. 8: Receiving Lenvatinib Therapy for Iodine-Refractory DTC

April 21st 2022

Expert and patient perspectives on receiving lenvatinib therapy for iodine-refractory differentiated thyroid cancer.

EP. 9: Radioiodine-Refractory DTC: Dosing Considerations for Lenvatinib Therapy

April 28th 2022

Considerations for how dosing and dose reductions can be used to optimize use of lenvatinib for iodine-refractory DTC.

EP. 10: Communicating With Care Providers While on Therapy for DTC

April 28th 2022

Discussion on how best to communicate with care providers while undergoing therapy for iodine-refractory differentiated thyroid cancer.

EP. 11: Practical Advice and Resources for Patients on Systemic Therapy for DTC

May 5th 2022

Shared practical advice for patients who may be undergoing treatment for iodine-refractory differentiated thyroid cancer.

EP. 12: Treating Radioiodine-Refractory DTC After Progression on Lenvatinib

May 5th 2022

A brief discussion on therapeutic options one may consider after progression on lenvatinib therapy for iodine-refractory DTC.

EP. 13: Addressing Unmet Needs in Differentiated Thyroid Cancer

May 12th 2022

Before closing out their discussion on differentiated thyroid cancer, patients and health care professionals alike consider unmet needs in this space.